Alexion Pharmaceuticals

Listing Websites about Alexion Pharmaceuticals

Filter Type:

Alexion Pharmaceuticals Company Profile - Office Locations, Competitors, Revenue, Financials, Employees, Key People, Subsidiaries Craft.co

(Just Now) Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders. Announcement The FDA approved our long-acting C5 complement inhibitor for adults with generalized myasthenia gravis.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion Pharmaceuticals - Wikipedia

(3 days ago) Alexion Pharmaceuticals, a subsidiary of AstraZeneca, is an American pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases.
Its products include eculizumab (Soliris) with $4.064 billion in 2020 revenues and ravulizumab (Ultomiris) with $1.076 billion in 2020 revenues, both used to trea…

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion Pharmaceuticals - Forbes

(7 days ago) Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion Pharmaceuticals Company Profile - Craft

(Just Now) Alexion Pharmaceuticals has 3,082 employees across 24 locations and $6.07 B in annual revenue in FY 2020. See insights on Alexion Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


ALXN Stock News ALEXION PHARMACEUTICALS Stock Price …

(3 days ago) Alexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic products aimed at treating patients with

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion Pharmaceuticals Reviews Glassdoor

(5 days ago) Alexion Pharmaceuticals has an overall rating of 3.9 out of 5, based on over 649 reviews left anonymously by employees. 62% of employees would recommend working at Alexion Pharmaceuticals to a friend and 53% have a positive outlook for the business. This rating has improved by 4% over the last 12 months.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


AstraZeneca to acquire Alexion, accelerating the …

(6 days ago) AstraZeneca and Alexion Pharmaceuticals, Inc. (Alexion) have entered into a definitive agreement for AstraZeneca to acquire Alexion. Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares (ADSs) (each ADS representing one-half of one (1/2) ordinary share of AstraZeneca, as evidenced by American Depositary …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


AstraZeneca’s $39 billion takeover of U.S.-based Alexion

(1 days ago) The U.K.’s Competition and Markets Authority said on Tuesday it was opening a consultation on the $39 billion planned takeover of U.S. drug company Alexion Pharmaceuticals, to determine whether

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Press Releases Alexion Pharmaceuticals, Inc.

(1 days ago) Alexion Announces Positive Topline Results from Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Adults with Generalized Myasthenia Gravis (gMG) Jun 11, 2021. Caelum and Alexion Present Additional Phase 2 Data Reinforcing Safety and Tolerability of CAEL-101 in AL Amyloidosis at the European Hematology Association Congress 2021. Jun 07, 2021.

Url: Visit Now

Category:  Health Detail Drugs


AstraZeneca to buy Alexion for $39 billion to expand in immunology

(2 days ago) The stock is up nearly 17% this year. Britain’s AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in its largest-ever deal, diversifying away from its fast

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Acquisition of Alexion completed

(8 days ago) AstraZeneca today completed the acquisition of Alexion Pharmaceuticals, Inc. (Alexion). The closing of the acquisition marks the Company’s entry into medicines for rare diseases and the beginning of a new chapter for AstraZeneca. AstraZeneca now has an enhanced scientific presence in immunology and, through Alexion’s innovative complement

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion (ALXN) to Be Acquired by AstraZeneca for $39 Billion

(3 days ago) Published. Dec 14, 2020 12:10PM EST. Alexion Pharmaceuticals, Inc. ALXN entered into a definitive agreement with U.K.-based pharmaceutical company, AstraZeneca plc AZN, whereby the latter will

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion Pharmaceuticals (ALXN) Stock Forecast, Price & News

(6 days ago) Alexion Pharmaceuticals, Inc. has collaboration and license agreement with Halozyme Therapeutics, Inc.; and agreements with Dicerna Pharmaceuticals, Inc., Zealand Pharma A/S, Caelum Biosciences, Inc., Stealth BioTherapeutics Corp., and Affibody AB. The company was founded in 1992 and is headquartered in Boston, Massachusetts.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion Pharmaceuticals - ALXN - Stock Price & News The Motley …

(9 days ago) The drugmaker got caught up in spiking market volatility last month. Alexion Pharmaceuticals Dropped 19.4% in October, but the Business Remains Strong. Maxx Chatsko …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion Pharmaceuticals, Inc. LinkedIn

(6 days ago) Alexion Pharmaceuticals, Inc. Biotechnology Research Boston, Massachusetts 228,775 followers Rare inspiration. Changing lives.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion OneSource™ Personalized Patient Support

(9 days ago) Alexion OneSource™ is here to help with personalized support throughout treatment with Alexion products

Url: Visit Now

Category:  Health Detail Drugs


Working at Alexion Pharmaceuticals Glassdoor

(9 days ago) 1992. Type: Company - Public (ALXN) Industry: Biotech & Pharmaceuticals. Revenue: $2 to $5 billion (USD) Competitors: Unknown. People living with rare and devastating diseases are our Guiding Star. We believe it is our responsibility to listen to, understand, and change the lives of patients and those who work tirelessly to help them.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Working at Alexion Pharmaceuticals,Inc.: 118 Reviews - Indeed

(3 days ago) Indeed’s Work Happiness survey asked over 31 current and former employees whether their manager at Alexion Pharmaceuticals,Inc. helped them succeed. 32% of the respondents said that they strongly agreed that their manager helped them succeed, and 23% said that they agreed. Companies.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion Pharmaceuticals - Crunchbase Company Profile & Funding

(3 days ago) Alexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer, and autoimmune disorders.

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


Activist investor Elliott pushes Alexion Pharma to sell itself

(7 days ago) Alexion is currently valued at $22 billion, and a sale would be a large deal by the standards of the drug industry, likely reaching more than $40 billion at …

Url: Visit Now

Category:  Health Detail Drugs


Alexion Pharmaceuticals : Termination of Material Definitive …

(5 days ago) On the Closing Date, in connection with the completion of the Mergers, Alexion paid all amounts owed and terminated all commitments under the Amended and Restated Credit Agreement, dated as of June 7, 2018 (the ' BoA Credit Agreement '), among Alexion, Alexion Pharma Holding Unlimited Company, a company incorporated in Ireland with company …

Url: Visit Now

Category:  Health Detail Drugs


With the Alexion Acquisition Set to Close This Quarter, Is …

(3 days ago) With UK approval, the $39 billion deal for rare disorders biotech company Alexion Pharmaceuticals is set to close on July 21. This week, pharma and biotech giant AstraZeneca ( AZN -0.91%) cleared

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion Careers Job Search Results

(5 days ago) AstraZeneca completed its acquisition of Alexion, marking the creation of Alexion, AstraZeneca Rare Disease. If you’re interested in career opportunities with AstraZeneca, click here.. If you are a current Alexion employee, please apply via Alexion’s internal Life & Career portal.Note that you will need to be connected to the VPN if you are applying away from the office.

Url: Visit Now

Category:  Health Detail Drugs


Search Alexion Pharmaceuticals, Inc.

(2 days ago) Alexion Announces Positive Topline Results from Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Adults with Generalized Myasthenia Gravis (gMG) July 15, 2021 - … in the U.S. , European Union and Japan in late 2021/early 2022. "The treatment landscape for people living with gMG has ….

Url: Visit Now

Category:  Health Detail Drugs


ALXN Alexion Pharmaceuticals, Inc. — Stock Price and Discussion

(4 days ago) Alexion Pharmaceuticals, Inc. NASDAQ Updated Jul 20, 2021 11:28 PM ALXN 182.50 3.05 (1.70%). Post-Market 0.50 (0.27%)

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion Pharmaceuticals (ALXN) is Overbought: Is A Drop Coming?

(5 days ago) Alexion Pharmaceuticals, Inc. ALXN has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because ALXN is now in overbought territory with an

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion Pharmaceuticals Strikes Tentative $25 Million Bribery

(2 days ago) Alexion Pharmaceuticals Inc. has reached a tentative settlement with U.S. authorities under which the company would pay less than $25 million to resolve claims it violated an antibribery law.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion Pharmaceuticals, Inc. Company Profile Boston, MA

(1 days ago) Doing Business As: Alexion Pharmaceuticals, Inc. Company Description: Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. Alexion focuses its research efforts on novel

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


SEC Charges Alexion Pharmaceuticals With FCPA Violations

(7 days ago) Washington D.C., July 2, 2020 —. The Securities and Exchange Commission today announced that Boston-based pharmaceutical company Alexion Pharmaceuticals Inc. has agreed to pay more than $21 million to resolve charges that it violated the books and records and internal accounting controls provisions of the Foreign Corrupt Practices Act (FCPA).

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion Pharmaceuticals - ESG News & Media

(7 days ago) Alexion Pharmaceuticals ON SOCIAL MEDIA. Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing therapies. As the global leader in complement biology and inhibition for more than 20 years, Alexion has developed and

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion Pharmaceuticals U.S. (@AlexionPharmaUS) / Twitter

(5 days ago) Official Twitter feed of Alexion Pharmaceuticals in the U.S. Community guidelines: https://t.co/Ud8NUo6ff2

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion Pharmaceuticals: Good Growth But Out Of Favor

(1 days ago) Alexion has been on an acquisition spree. It has spent nearly $4 billion in the last 2-3 years acquiring several drug companies. Considering that the pharma industry thrives on innovation and R&D

Url: Visit Now

Category:  Health Detail Drugs


César Tapia - Associate Director, Operational Excellence - Alexion

(3 days ago) Alexion Pharmaceuticals, Inc. Report this profile About Seasoned Operational Excellence practitioner and certified ASQ Six Sigma Black Belt with over 10 …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion Pharmaceuticals,Inc. Careers and Employment Indeed.com

(5 days ago) Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company engaged in the discovery, development and delivery of biologic therapeutic products for the treatment disease, including hematologic and neurologic diseases, cancer and autoimmune disorders. The Company has one marketed product, Soliris (eculizumab), which is a therapy

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


AstraZeneca concludes Alexion acquisition for $39bn

(9 days ago) AstraZeneca has concluded the acquisition of US-based biopharmaceutical company Alexion Pharmaceuticals for a total consideration of $39bn or $175 per share. The Alexion shareholders received total consideration of $13.3bn in cash and 236,321,411 new AstraZeneca shares. With the acquisition, AstraZeneca will enter the rare disease therapies

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


ALEXION PHARMACEUTICALS, INC. : ALXN Stock Price

(2 days ago) 91,0%. More Financials. Company. Alexion Pharmaceuticals, Inc is a biopharmaceutical company. The Company is focused on discovering, development and commercialization of medicines. The Company’s marketed products include ULTOMIRIS, SOLIRIS (eculizumab), STRENSIQ (asfotase alfa), KANUMA (sebelipase alfa) and ANDEXXA (coagulation Factor Xa

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Alexion News Latest News - NewsNow

(9 days ago) Alexion News. NewsNow aims to be the world's most accurate and comprehensive aggregator of Alexion news, covering the latest share price, drug news, biotech news and more from the best online news publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Url: Visit Now

Category:  Health Detail Drugs

Popular Searched

 › Cyp2d6 substrates drug list

 › Cms managed care manual chapter 6

 › Fort hood pharmacy formulary

 › Biggest pharmacy benefit managers

 › Optumrx retail pharmacy list

 › Sweetwater county wyoming public health

 › Myuhcmedicare.com hwp sign in

 › Georgia family medicine watkinsville ga

 › Aetna formulary drug list 2022

 › Spectrum health connect log in

Recently Searched

 › Aetnamedicare.com plan documents

 › Metro health cedar springs mi

 › Cvs pharmacy in ruston la

 › Webmd pill identifier prescription drugs

 › Palliative care board exam

 › Optum rx pharmacy locator

 › Drug mart tallmadge ohio

 › United health one customer service number

 › Medical office charge sheets

 › Tricare active duty copay

FAQ about Alexion Pharmaceuticals

What does Alexion Pharmaceuticals do?

Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH).

Is Alexion Pharmaceuticals (ALXN) in overbought territory?

Alexion Pharmaceuticals, Inc. ALXN has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because ALXN is now in overbought territory with an RSI value of 75.39. What is RSI?

How much do Alexion drugs cost?

With costs that can reach as much as $2 million per year, the drugs manufactured by Alexion are some of the most expensive drugs worldwide.